DATA-DRIVEN DRUG DISCOVERY
Webinar series focusing on data-driven drug discovery in various therapeutic areas.
Data-Driven Drug Discovery
How Single-Cell Atlases and AI Are Reshaping Drug Discovery
Large-scale single-cell datasets are creating new opportunities to understand biology,...
QIAGEN IPA
AI meets expertise: A hybrid workflow for modern target ID
AI excels at identifying patterns and generating insights across large datasets, but...
QIAGEN OmicSoft and Biomedical Knowledge Base
Beyond enrichment Causal discovery powered by Neo4j & QIAGEN Discovery KB+
One click from your target gene to disease drivers, drug candidates and causal...
Data-Driven Drug Discovery
QIAGEN and NVIDIA collaboration to advance AI driven drug discovery
NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to drug...
QIAGEN OmicSoft and Biomedical Knowledge Base
Immunology: Guide the immunology drug discovery lifecycle with ‘omics...
The autoimmune drug market is dominated by blockbuster biologics, including Janssen’s...
QIAGEN OmicSoft and Biomedical Knowledge Base
Oncology: De-risking target evaluation and indication expansion with curated...
The early stages of drug development are inherently high-risk; molecule screening,...